Nasdaq · Common Stock · Services-Medical Laboratories
69 entities across 46 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-26 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Fortrea Argentina S.A. | Argentina | |
| Fortrea Australia Pty Ltd | Australia | |
| Fortrea Austria GmbH | Austria | |
| Fortrea Belgium SRL | Belgium | |
| Fortrea Brazil Limitada | Brazil | |
| Theorem Research Associates, Inc. | California | |
| Fortrea Canada Inc. | Canada | |
| Fortrea Chile Limitada | Chile | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Chengdu Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Nanjing Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Shanghai Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co Ltd, Xi’an Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd. Dalian Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd. Guangzhou Branch | China | |
| Fortrea Pharmaceutical Research & Development (Beijing) Co., Ltd., Hangzhou Branch | China | |
| Fortrea Pharmaceutical Research and Development (Beijing)Co., Ltd. | China | |
| Fortrea Colombia Ltda | Colombia | |
| Fortrea Development Limited odštěpný závod | Czechia | |
| Fortrea Asia-Pacific Inc. | Delaware | |
| Fortrea CRU Inc. | Delaware | |
| Fortrea Holdings Inc. | Delaware | |
| Fortrea Latin America Inc. | Delaware | |
| Fortrea Receivables LLC | Delaware | |
| SnapIoT, Inc. | Delaware | |
| Fortrea Denmark ApS | Denmark | |
| Fortrea Development Limited Suomen sivuliike | Finland | |
| Fortrea Clinical Research Unit Inc. | Florida | |
| Fortrea France SARL | France | |
| Fortrea Germany GmbH | Germany | |
| Fortrea Development Limited Greek Branch | Greece | |
| Fortrea Hong Kong Limited | Hong Kong | |
| Fortrea Hungary Kft | Hungary | |
| Fortrea Clinical Development Pvt Ltd | India | |
| Fortrea Development India Private Limited | India | |
| Fortrea Scientific Private Limited | India | |
| Fortrea Ireland Limited | Ireland | |
| Fortrea Development Limited | Israel | |
| Fortrea Development Limited Filiale Italiana | Italy | |
| SnapIoT Europe s.r.l. | Italy | |
| Fortrea Japan K.K. | Japan | |
| Fortrea Malaysia Sdn. Bhd. | Malaysia | |
| Fortrea Inc. | Maryland | |
| Fortrea Clinical Development Mexico S.DeR.L.DeC.V. | Mexico | |
| Fortrea Netherlands B.V. | Netherlands | |
| Theorem Clinical Research Holdings B.V. | Netherlands | |
| Theorem Clinical Research International B.V | Netherlands | |
| Theorem Clinical Research Latin America B.V. | Netherlands | |
| Fortrea New Zealand Limited | New Zealand | |
| Fortrea GP, Inc. | Nevada | |
| Fortrea Research Holdings LLC | Nevada | |
| Fortrea Peru S.A. | Peru | |
| Fortrea Philippines Inc. | Philippines | |
| Fortrea Poland Sp. z o.o. | Poland | |
| Fortrea Development Limited Sucursal em Portugal | Portugal | |
| Fortrea Development Limited Maidenhead Sucursala Bucuresti | Romania | |
| Fortrea Singapore Pte. Ltd. | Singapore | |
| Fortrea South Africa (Pty) Limited | South Africa | |
| Fortrea Spain SA | Spain | |
| Fortrea Development Limited Sverige filial | Sweden | |
| Fortrea Switzerland AG | Switzerland | |
| Fortrea (Thailand) Limited | Thailand | |
| Fortrea Turkey Clinical Study Limited Company | Turkey | |
| Fortrea Clinical Research LP | Texas | |
| Fortrea Data Sciences Ukraine LLC | Ukraine | |
| Fortrea Development Ukraine LLC | Ukraine | |
| Chiltern International Limited (CIL) | United Kingdom | |
| Fortrea Clinical Research Unit Limited | United Kingdom | |
| Fortrea UK Holdings Limited | United Kingdom | |
| Havenfern Ltd | United Kingdom |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2021 | $3.1B | $98.0M | $143.3M | — | 88,800,000 |
| FY2022 | $3.1B | $192.9M | $33.1M | — | 88,800,000 |
| FY2023 | $3.1B | −$3.4M | $127.1M | — | 88,800,000 |
| FY2024 | $2.7B | −$328.5M | $237.3M | — | 89,500,000 |
| FY2025 | $2.7B | −$986.2M | $88.3M | — | — |
1 institutions tracked — 1 added, 0 reduced.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Index | 2,546,771 | +180,294 | $44.3M |
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
Fortrea Holdings Inc. files under SIC 8071 — all 5 services-medical laboratories companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.